The association of nephronophthisis and tapeto-retional degeneration was described by both Senior and Loken in 1961 [1
]. It occurs in approximately 10-15% of all the cases of nephronophthisis. In addition to the ocular involvement, the clinical and the pathological features of the Senior Loken syndrome are similar to those of isolated nephronophthisis.
The ocular involvement takes several forms: It could be early and severe congenital amaurosis of the Leber type or late-onset pigmentary retinal degeneration which was characterized by night blindness, which was followed later by complete visual loss. Leber’s congenital amaurosis represents a severe form of ocular involvement which leads to blindness in infancy, nystagmus and a diffuse atypical retinal pigmentation with narrowing of the retinal arteries and pallor of the optic disc, with an early and complete extinction of the electroretinogram (ERG) [7
]. The tapetoretinal degeneration varies in its nature and severity and it is the commonest form. It is characterized by a progressive degeneration of the choroid and the retina. Retinitis pigmentosa is characterized by bone spicule degeneration that begins from the periphery of the retina and extends to involve the whole of retinochoroid [8
]. Retinitis pigmentosa is seen in most of the NPHP genes mutations, but it is more severe in the patients with the NPHP 5 and the NPHP 6 gene mutations [5
]. The other ocular findings include cataract, Coat’s disease and keratoconus [9
The retinal disease may become progressive and so an annual eye examination which commences at the time of the diagnosis is recommended. An electroretinogram (ERG) helps in the diagnosis of these varieties before the retinitis pigmentosa may be observed by a fundoscopic examination.
Nephronophthisis is a disorder which was first described in 1945. It is characterized by chronic tubulointerstitial nephritis that progresses to ESRD during the second decade. To date, the mutations in 9 genes (NPHP1-9) have been identified as the causative agents which are responsible for nephronophthisis [10
]. Basically, there are three clinical variants of nephronophthisis according to the age of onset of the ESRD [4
Firstly, the severe infantile form of nephronophthisis which is associated with blindness in infancy, severe hypertension and death from renal failure before the age of ten. It is caused by the mutations in the NPHP2 gene which is located on chromosome 9q31. It is associated with some extrarenal features which are peculiar to infantile nephronophthisis, which include hypertension, situs inversus, and ventricular septal defects [4
Secondly, the adolescent form is caused by mutations in the NPHP3 gene which is located on chromosome 3q22, in which ESRD occurs in early adulthood and the histological features are similar to those of the juvenile form [4
Thirdly, the juvenile form is the most common type of nephronophthisis and it represents about 5-10% of all the cases of ESRD in children. It affects both the genders equally [4
]. It is caused by mutations in eight different genes (NPHP 1, 3, 4, 5, 6, 7, 8 and 9) [11
]. NPHP1 is the commonest gene (in 25% of the cases) which is responsible for juvenile nephronophthisis. It is characterized by a later onset, a slower progression of the renal disease and milder ocular manifestations. The renal involvement is often asymptomatic and mild. The earliest signs are decreased urinary concentration ability, which leads to polyuria, polydipsia and renal sodium loss by the age of 4-6 years [12
]. Proteinuria and haematuria are absent or minimal and the urinary sediment is often normal. The blood pressure remains normal until the development of the chronic renal failure. The disease progresses invariably to CKD before the age of 20 years [3
]. However, a late onset of the renal disease in the third and fourth decades was described in two siblings from Greece [13
The ultrasonographic findings of juvenile nephnonophthisis may be normal or they may show an increased echogenicity of the renal parenchyma, a poor corticomedullary differentiation, a small kidney size, and medullary cysts. However, the lack of medullary cysts at presentation does not rule out the diagnosis of juvenile nephronophthisis [14
The main histological findings in the kidney biopsies of the juvenile form are moderate to severe tubulointerstitial fibrosis, tubular dilatation and tubular atrophy, with thickening and multilayering of the tubular basement membrane. The glomeruli are basically normal, but a secondary glomerosclerosis can be seen in advanced nephronophthisis. Whereas, the infantile form shows cortical microcysts and a cystic dilatation in the collecting ducts, rather than the thickening and multilayering of the tubular basement membrane that is seen in the juvenile form [5
Nephronophthisis should not be confused with autosomal dominant polycystic kidney disease (ADPKD) which is characterized by bilateral, multiple renal cysts or medullary cystic kidney disease (MCKD), which shares macroscopic and microscopic features with nephronophthisis. However, unlike nephronophthisis, ADPKD and MCKD are inherited in an autosomal dominant pattern and they progress to ESRD at later ages. The diagnosis of nephronophthisis is based on the genetic testing, the clinical features and the pathological findings [15
To date, there are no proven treatments for nephronophthisis. The management depends mainly on delaying the progression of the renal failure, which leads to ESRD and the need for dialysis and transplantation. The management in a low clearance renal clinic is appropriate, to allow time for the consideration of renal replacement therapies. Successful renal transplantations have been performed in patients with juvenile nephronophthisis, without the recurrence of the disease in the transplanted organ. Newer agents, vasopressin V2 receptor antagonists, which alter the cystogenesis and the progression of the disease may be available for future use [16
To the best of our knowledge, this is the first report on the rare Senior Loken syndrome from the state of Qatar. It must be considered in patients who present with visual impairment and renal failure at early ages. There is no specific treatment; however, renal transplantation is the preferred therapy because nephronophthisis will not recur after transplantation.